Nateglinide | B2109

Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release. Used to treat type 2 diabetes mellitus.

Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release. Used to treat type 2 diabetes mellitus.

B2109 | Nateglinide DataSheet

Alternate Name/Synonyms: N-[[4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine

Appearance: White solid

Formulation: N/A

CAS Number: 105816-04-4

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₉H₂₇NO₃

Molecular Weight: 317.42

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (~30 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: An oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM)

MDL Number: MFCD00875706

PubChem CID: 5311309

SMILES: CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O

InChi: InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1

InChi Key: OELFLUMRDSZNSF-OFLPRAFFSA-N